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Summary 
The nonpolymorphic human class II molecule HLA-DM 
(DM) has been found to play a key role in antigen pre- 
sentation by MHC class II molecules. HLA-DM and its 
murine equivalent H2-M are located intracellularly and 
are absent from the cell surface. In transfected HeLa 
cells, H2-M was transported to an endosomal compart- 
ment in the absence of invariant chain. A tyrosine- 
based targeting motif in the cytoplasmic tail of H2-Mf3 
was responsible for the endosomal location and, if this 
tyrosine was mutated, H2-M accumulated at the’cell 
surface. In the presence of invariant chain the mutated 
H2-M was redistributed to endosomes. The targeting 
motif of H2-M appeared not to be crucial for efficient 
peptide loading of class II, but if the invariant chain 
targeting motif also was removed, peptide loading de- 
creased drastically. Thus, the targeting motif of H2-M 
appears to be supplementary, rather than essential for 
class II-peptide association. 
Introduction 
Major histocompatibilitycomplex(MHC) class II molecules 
present foreign antigens to CD4+ T cells. Though exten- 
sively studied, antigen processing and binding of peptides 
to class II molecules is still poorly understood. Class II 
molecules are noncovalently linked heterodimeric cell sur- 
face glycoproteins consisting of an a and a 6 chain. In the 
endoplasmic reticulum (ER), shortly after synthesis, class 
II associates with a third chain, the invariant chain (Ii) (Kvist 
et al., 1962). The Ii has three well-described properties: 
it blocks binding of peptides and proteins to class II in the 
ER; it facilitates class II transport out of the ER; and it 
directs class II to endosomes where peptide loading oc- 
curs (reviewed by Cresswell, 1994; Germain, 1994). The 
class II-Ii complexes are sorted for delivery to endosomal 
compartments, but it is unclear whether this sorting occurs 
in the trans-Golgi network or at the cell surface (Neefjes 
et al., 1990; Roche et al., 1993). In the endosomal system, 
Ii is degraded and released from class II, which returns 
to the cell surface after having bound peptides. The exact 
location of peptide loading is debated, but several groups 
have described distinct class II-rich compartments with 
late endosomal or lysosomal characteristics (Qiu et al., 
1994; West et al., 1994). A morphologically defined com- 
partment called MHC class II compartment (MIIC) (Peters 
et al., 1991) has similar characteristics. The data support- 
ing a function for these structures in peptide loading are 
largely circumstantial, however, and other groups have 
described other specialized compartments as being the 
site for peptide loading (Amigorena et al., 1994), or have 
been unable to find any specialized compartment at all 
(Castellino and Germain, 1995). 
The signals responsible for targeting the class II-Ii com- 
plex to endosomes have been well characterized (Odorizzi 
et al., 1994; Pond et al., 1995). Ii contains two leucine- 
based targeting motifs in its N-terminal cytoplasmic do- 
main, similar to motifs described in several other endoso- 
mal and lysosomal proteins (Letourneur and Klausner, 
1992; Ogata and Fukuda, 1994). If both these motifs are 
deleted or mutated, Ii is not targeted to endosomes, but 
accumulates at the cell surface. 
Human B cell lines lacking the MHC-encoded class II- 
like molecule HLA-DM have been shown to be deficient 
in presentation of whole protein antigens, despite the fact 
that they can present exogenously added peptide antigens 
and contain normal class II and invariant chain genes (Mel- 
lins et al., 1990). Cell lines with large deletions in the class 
II region, but where class II genes have been reintroduced 
by transfection, have a similar phenotype (Ceman et al., 
1992; Riberdy et al., 1992). Reintroduction into these cell 
lines of the HLA-DM a and 6 chains (or the equivalent 
mouse molecules, H2-M), by transfection, restored anti- 
gen presentation ability (Denzin et al., 1994; Fling et al., 
1994; Morris et al., 1994). The class II molecules present 
in the (nontransfected) mutant cell lines have several char- 
acteristics that set them apart from class II molecules in 
normal B cell lines. First, certain monoclonal antibodies 
(MAbs) react poorly with the class II molecules expressed 
by the mutant cell lines, despite the fact that class II can 
be detected with other antibodies (Mellins et al., 1990). 
Second, class II molecules from normal B cell lines are 
relatively stable to denaturing agents and migrate as heter- 
odimeric complexes in SDS-PAGE gels, as long as sam- 
ples are not heated. The formation of SDS-stable dimers 
has been correlated with peptide binding (Sadegh-Nasseri 
and Germain, 1991; Stern and Wiley, 1992), and the fact 
that class II molecules from the mutant cell lines were 
unstable in SDS indicated that their peptide content was 
abnormal. Third, class II-derived peptides eluted from cell 
lines lacking HLA-DM were found to consist mainly of in- 
variant chain peptides, derived from the class Il-associ- 
ated Ii peptides (CLIP) region of Ii (Mellins et al., 1994; 
Riberdy et al., 1992). These peptides have also been de- 
tected using CLIP-specific antibodies (Awa and Cress- 
well, 1994; Denzin et al., 1994). A recent report has de- 
scribed the ability of recombinant HLA-DM to induce 
peptide exchange in purified HLA-DR (DR) in vitro and the 
lack of this function is likely to account for the phenotype 
seen in the mutant cell lines (Sloan et al., 1995). We found 
that we could mimic the situation in the mutant B cell lines 
by transient transfection of HeLa cells (Karlsson et al., 
1994). Class II molecules extracted from transiently trans- 
fected HeLa cells expressing class II and Ii are unstable in 
SDS. However, if H2-M is also included in the transfection, 
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class II becomes SDS-stable, thus indicating peptide load- 
ing of class II. These data implicate that, in mammalian 
cells, class II, Ii, and H2-M are the minimally required spe- 
cialized components necessary for efficient class Il-pep- 
tide association. They do not exclude however that other 
molecules may be involved in modulating the peptide load- 
ing process. 
Both HLA-DM and H2-M have been shown to be endoso- 
mal or lysosomal residents that are largely absent from 
the cell surface (Karlsson et al., 1994; Sanderson et al., 
1994). Both HLA-DMP and HBMP contain sequences in 
their cytoplasmic tails resembling the tyrosine-based en- 
dosomal targeting sequences seen in many other endoso- 
mal and lysosomal resident proteins (Trowbridge et al., 
1993), and we found that H2-M was present in endosomes 
also in the absence of Ii, indicating that it may indeed 
contain targeting information of its own (Karlsson et al., 
1994). 
In this report, we describe the existence of a targeting 
motif in the cytoplasmic tail of the H2-Mb chain, which can 
function independently, but which does not appear to be 
critical for the function of H2-M. We do find, however, that 
endosomal targeting (provided by Ii) is necessary for nor- 
mal peptide loading to occur. 
Results 
H-MP Contains an Endosomal Targeting Motif 
HLA-DM has been shown by immuno-electron microscopy 
to be present in the class II-rich endosomalllysosomal 
compartments called MIIC (Sanderson et al., 1994). We 
have previously described the transport of H2-M to com- 
partments with similar characteristics in HeLa cells ex- 
pressing only H2-M a and p, but not Ii. To investigate the 
structural basis for the H2-M targeting, we transiently 
transfected HeLa cells with constructs encoding modified 
forms of H2-M. The different constructs are described in 
Figure 1. The H2-MP sequence contains a motif in the 
cytoplasmic domain similar to previously described endo- 
somalllysosomal targeting motifs, and we therefore made 
a deletion mutant of the HPMP chain lacking the cyto- 
plasmic tail. This cDNA was transfected together with the 
H2-Ma cDNA into HeLa cells and the localization of the 
deletion mutant H2-MA was monitored by immunofluores- 
cence using a rabbit serum, K553, reacting with the lume- 
nal part of the H2-M heterodimer (Karlsson et al., 1994). 
In contrast with the vesicular staining of cells transfected 
with wild-type H2-M (Figure 2A), H2-MA was localized to 
the cell surface (Figure 2C), suggesting that H2-M was 
indeed targeted to vesicular structures by a targeting motif 
located in the cytoplasmic tail of the HP-Mb chain. 
The HBMP tail contains two tyrosines that could poten- 
tially be part of tyrosine-based targeting motifs, though 
the first of these, Y230, is surrounded by amino acids most 
reminiscent of previously described motifs. We made two 
H2-MB constructs substituting either the membrane proxi- 
mal tyrosine (Y230) orthe membrane distal tyrosine (Y238) 
with alanine. The two constructs were transfected into 
HeLa cells together with H2-Ma and analyzed by immuno- 
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Figure 1. Amino Acid Sequences of the Cytoplasmic Tails of the H2-M 
and H2-Ah Constructs Used in This Study 
The wild-type H2-ABk and the H2-Mb2 cyloplasmic sequences are 
shown. The two tyrosines in the H2-Mb2 tail that were mutated to 
alanines are shown in bold. The H2-APVH2-M chimeras contain wild- 
type H2-ABk extracellular and transmembrane domains with wild-type 
or mutated forms of HZ-MB cytoplasmic domains, as indicated. All 
H2-M and H2-A* transfections were made with both (I and fl chains 
present. The a chains used were always wild type. 
fluorescence of permeabilized cells. Figure 2D shows the 
vesicular staining pattern of cells transfected with the H2- 
M(Y238+A) construct, while cells transfected with H2- 
M(Y230+A) displayed strong cell surface staining without 
any distinct vesicular staining (Figure 2E). The vesicles 
seen in the H2-M and H2-M(Y238+A) transfections largely 
costained with the lysosomal marker lamp-l (Fukuda, 
1991) (Figure 28; data not shown). In a separate experi- 
ment, the cell surface expression of the different H2-M 
constructs was analyzed by FACS. Nonpermeabilized 
transiently transfected HeLa cells were stained with K553 
or, separately, with OKT8, reacting with cotransfected hu- 
man CD8. Wild-type H2-M and H2-M(Y238+A) showed 
low cell surface staining, while H2-MA and H2-M(Y230+A) 
were abundant at the plasma membrane. We have not 
been able to detect any differences between H2-MA and 
H2-M(Y230-A) either in this or other experiments where 
we have analyzed both constructs. A construct with both 
tyrosines mutated to alanines was also located at the cell 
surface (data not shown). We concluded that the mem- 
brane proximal tyrosine (Y230) in the HP-M@ tail is neces- 
sary for the targeting of H2-M to endosomal structures in 
the absence of Ii. 
The HS-MB Cytoplasmic Tail Transferred to HS-ABk 
Changes the Subcellular Localization of H2-AL 
The HP-MB chain cytoplasmic sequence clearly contained 
an endosomal targeting motif, but to show that the motif 
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Figure 2. Subcellular Localization of Wild-Type and Mutated Forms of H2-M 
HeLa cells were transiently transfected with different forms of H2-M cDNAs. The cells were fixed 72 hr after transfection in 4% formaldehyde and 
permeabilized with 0.2% saponin. Cells were double-stained with a rabbit serum, K553, reactive with H2-M and a mouse MAb reactive with lampl. 
Secondary antibodies were fluorescein-labeled goat anti-rabbit immunoglobulin G (IgG) and Texas red-labeled goat anti-mouse IgG. Wild-type 
H2-M localized to vesicular structures (A), which largely costained with lamp-l (B). The H2-MA (C) and H2M(Y23O+A) (E) were located predominantly 
at the cell surface with no obvious vesicular staining. H2M(Y238+A) showed vesicular staining (D) colocalizing with lamp-l (data not shown). 
FACS analysis of nonpermeabilized cells (F) showed that little wild-type H2-M or H2-M(Y238+A) was present at the cell surface, while H2-MA 
and H2-M(Y230-A) were abundant in this location. OKT8 staining of cotransfected CD8 was made separately and used for standardization of 
the transfection efficiency. 
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Figure 3. The HP-M6 Cytoplasmic Tail Transferred to HP-Apk Redistributes H2-AL to Vesicles in the Absence of Ii Targeting 
HeLa cells were transfected with either H2-Ak (A), HP-AYM (B), or H2-AYM(Y23Ct-A) (C). Permeabilized cells were stained with MAb 10-2-16 
followed by Texas red-labeled goat anti-mouse IgG. The chimeric HP-AK/M was localized to vesicular structures, while both wild-type H2-AL and 
H2-KIM(Y2304A) were localized mainly to the cell surface without any vesicular intracellular staining. 
acted independently of the rest of the H2-M molecule we 
exchanged the tail of the H2-Ak 6 chain for the wild-type 
or point-mutated HPM6 tail. The H2-Ak a chain (which was 
included in all transfections) was not changed. H2-Ak was 
chosen as a reporter molecule since, like H2-M, it is a 
heterodimer and since H2-A is relatively resistant to the 
denaturing conditions in the late endosomalllysosomal 
compartments where H2-M is located (Jensen, 1992; Lee 
et al., 1992). Though H2-Ak has been reported to be endo- 
cytosed by itself in certain cell types, it is well documented 
that this is not the case in HeLa cells (Chetvonsky et al., 
1994; Simonsen et al., 1993). 
Immunofluorescence-staining of HeLa cells expressing 
wild-type H2-Ak using the H2-Ak-specific MAb 10-2-16 
showed that this molecule was located mainly at the 
plasma membrane, without any vesicular staining (Figure 
3A). In contrast, the staining of cells transfected with H2-Ak 
where the 6 chain tail had been replaced with the wild-type 
HBMb tail (i.e., H2-Ak/M) was located to vesicular struc- 
tures (Figure 38). Little or no cell surface staining was 
seen, while the costaining with lamp-l was extensive (data 
not shown), thus mimicking the H2-M staining. In cells 
transfected with the H2-Ak/M(Y230+A) chimeric con- 
struct, the staining was again similar to the wild-type stain- 
ing, with 10-2-16 staining present at the cell surface, but 
not in vesicles (Figure 3C). 
Thus, the targeting motif in the HP-M6 cytoplasmic tail 
is functional when transferred to a reporter molecule and 
appears to be independent of other parts of H2-M. 
HP-MA Is Redistributed by Ii 
We have previously shown that Ii appears to be associated 
with H2-M in mouse splenocytes (Karlsson et al., 1994). 
This interaction may influence H2-M targeting in vivo, and 
to test this we transfected H2-MA (a and 6 chain) together 
with the main form of Ii, lip31. Human lip31 was used 
for the experiments shown in Figures 4 and 5 due to the 
availability of better antibodies, but we find that human 
and mouse Ii are equivalent in their interaction with H2-MA 
(data not shown). lmmunofluorescence staining with K553 
showed that H2-MA was located at the cell surface in the 
absence of lip31 (Figure 4A), as was the cotransfected 
marker 87-2 (Figure 48). In the presence of lip31, how- 
ever, the majority of the K553 staining was redistributed 
to intracellular vesicles, though some cell surface staining 
was also seen (Figure 4C). Colocalization with lamp-l was 
extensive (data not shown). The redistribution of H2-MA 
was specific, since the cotransfected marker 67-2 re- 
mained at the cell surface also in the presence of lip31 
(compare Figures 4C and 4D). Staining of cells with K553 
and VicYl, recognizing the cytoplasmic tail of Ii, showed 
the presence of HPMA and Ii in the same vesicular struc- 
tures (compare Figures 4E and 4F). Note that the li- 
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Figure 4. H2-MA Is Redistributed by Ii lip31 
HeLa cells were transfected with H2-MA and 87-2 (A and B) or H2-MA, 87-2, and human lip31 (C-F). H2-M expressed in transfected cells was 
localized predominantly to the cell surface (A),as was the cotransfected molecule 87-2 (B). In the presence of wild-type lip31, H2-MA was 
redistributed to vesicular structures (C), costaining with lamp-l (data not shown), but not with 87-2 (D). H2-MA (E) also colocalized with lip31 (F). 
Costainings were made with the rabbit antiserum K553 (A, C, E) and GLl (anti-B7-2) (B and D) or VicYl (anti Ii) (F). followed by fluorescein-labeled 
goat anti-rabbit IgG and Texas red-labeled goat anti-mouse IgG (F) or Texas red-labeled goat anti-rat IgG (B and D). 
containing vesicles seen in Figure 4 are not the large peri- 
nuclear vesicles (macrosomes) seen in transfected cells 
expressing very high levels of Ii (Pieters et al., 1993; Ro- 
magnoli et al., 1993). 
H2-M Associates with Ii 
Denzin et al. (1994) have reported that HLA-DM does not 
associate with Ii. The redistribution of H2-MA in the pres- 
ence of Ii supports our previous conclusion that Ii and 
H2-M interact, but to confirm this interaction we transfected 
HeLa cells with H2-MA and lip31A16, a cytoplasmically 
truncated form of Ii lacking endosomal targeting motifs 
(labeled IiA in Figure 5). This form of Ii was used since it 
accumulates at the cell surface and is more long-lived than 
the full-length li(Rocheet al., 1992). Thecellswerelabeled 
with [35S]methionine and [%]cysteine for 4 hr before lysis 
in 1% digitonin. The detergent extracts were split and im- 
munoprecipitated with either K553 or with MAb B045, di- 
rected against the lumenal part of human Ii. The samples 
were analyzed by two-dimensional gel electrophoresis. 
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Figure 5. H2-M Associates with Ii 
HeLa cells were transfected with cDNAs encoding H2-Ma (a), HP-MDA 
(pa), and human lip31A16 (IiA) in molar ratios 3:3:14. The cells were 
labeled 72 hr after transfection with [“Slmethionine and [?S]cysteine 
for 4 hr before lysis in 1% digitonin. Samples were split and radiola- 
beled molecules were immunoprecipitated with K553, reactive with 
H2-M (A) or with Sii45, reactive with human Ii (B). The samples were 
analyzed by two-dimensional gel electrophoresis. Acidic proteins are 
located to the right, basic proteins are to the left. Molecular mass 
markers (kDa) are positioned on the left. 
Figure 5Ashows the K553precipitated sample. In addition 
to the Ma and Mj3A spots, a series of more basic spots 
can be seen and the BMS-precipitated sample (Figure 
58) confirmed that these were derived from the ii. Ii was 
expressed in excess over H2-M in the transfection and Ma 
and M6A are therefore not visible in the Bti4Bprecipitated 
material. We found that lysis of cells with Triton X-100 
instead of digitonin resulted in poor coprecipitation of 
H2-M and Ii, unless cellular proteins were cross-linked with 
formaldehyde before lysis (data not shown). 
H2-M Targeting and the Effect on Class II 
SDS-Stable Dimer Formation 
Class II molecules containing bound peptides are often 
(but not always) resistant to denaturation in SDS and mi- 
grate as dimers in SDS-PAGE gels (Lanzavecchia et al., 
1992; Nelson et al., 1993; Stern and Wiley, 1992). We used 
formation of SDS-stable dimers as an assay to monitor the 
function of H2-M and the H2-M targeting motif in tran- 
siently transfected HeLa cells. Class II-positive cell lines 
express Ii in excess of class II and class II in excess of 
H2-M. In the experiments presented here, we tried to 
mimic these relationships to some extent by adjusting the 
amounts of the various transfected cDNAs. Note. how- 
ever, that lip41 is present in higher amounts than in a 
normal B cell. 
Cellswere transfected with HLA-DR3and Ii, either alone 
or together with H2-M or H2MA. The amountsof HLA-DR3 
and Ii were kept constant in each transfection and vector 
DNA was used to substitute for omitted DNA. Cells were 
labeled with [%]methionine for 30 min, then chased in 
medium containing excess nonradioactive methionine for 
different times as indicated in Figure 6. Detergent-solu- 
bilized material was immunoprecipitated with MAb DA6.147, 
reacting with the cytoplasmic tail of DRa. Samples were 
incubated in nonreducing SDS sample buffer for 15 min 
before analysis by SDS-PAGE. In Figure 6, lanes A repre- 
sent cells transfected with cDNAs encoding HLA-DR3 and 
Ii only, while lanes B and C represent cells where H2-M 
or H2-MA cDNAs were also included in the transfection. 
After the labeling (0 hr), a and 6 monomers of DR were 
seen together with the bands representing Ii. No SDS- 
stable DR a6 dimers were present. After 2 hr of chase, 
small amounts of SDS-stable DR dimers were present in 
lanes B and C, and after 4 hr a large part of the DR mole- 
cules migrated as up dimers in both these lanes. When 
H2-M was absent (Figure 6, lanes A) no SDS-stable dimers 
were formed even after 6 hr of chase. Both the kinetics 
of SDS-stable dimer formation and the final amount of 
SDS-stable dimers appeared to be the same whether 
H2-M or H2-MA was included in the transfection (Figure 
6, compare lanes B and C). In a separate experiment, 
pulse-labeling showed that the expression level was 
equivalent for the two H2-M constructs (data not shown). 
Thus, the targeting motif in the HP-M6 tail does not appear 
to be essential for the formation of SDS-stable dimers. 
Endosomal Targeting Is Necessary for Class II 
SDS-Stable Dimer Formation 
The ability of H2-MA to substitute for H2-M, despite the 
fact that it is lacking the HP-M6 targeting motif, prompted 
us to ask whether endosomal targeting by Ii was important 
for the formation of SDS-stable dimers. HeLa cells were 
transfected with HLA-DR3 (all transfections) and H2-M, 
H2-MA, lip31, or lip31A16 in different combinations as 
indicated (Figure 7). Whole cell extracts in SDS sample 
buffer were boiled (Figure 7, b lanes) or left at room temper- 
ature (Figure 7, nb lanes) before being subjected to SDS- 
PAGE and immunoblotting. Blots were probed with 
DA6.147. The DRa chain, recognized by this antibody, 
migrated as a 33-35 kDa doublet in all lanes. SDS-stable 
DR3 dimers (50 kDa in size) were formed in the presence 
of both wild-type H2-M and H2-MA as long as lip31 was 
present (Figure 7, lane 1, nb, and lane 3, nb). When 
lip31A.16 was substituted for lip31, however, no SDS- 
stable DR3 dimers were formed (Figure 7, lane 2, nb, and 
lane 4, nb). Therefore, endosomal targeting of class II (me- 
diated by Ii) appears to be essential for efficient SDS-stable 
dimer formation and most likely also for efficient class II- 
peptide loading, while the H2-M targeting motif appears 
not to be essential for loading DR3. In this experiment, 
the H2-M targeting motif could not substitute for the Ii sig- 
nal, but Ii DNA was present in an 6-fold excess over H2-M 
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DNA and it is possible that the H2-M motif would be suffi- 
cient to promote DR SDS-stable dimer formation if the 
ratios of H2-M and Ii were inverted. 
The antibody 16.23 is reported to recognize mature, pos- 
sibly peptide-containing, class II molecules (Mellins et al., 
1990; Monji et al., 1994). To confirm that mature HLA-DR3 
was indeed present in the endosomal compartments also 
in the absence of H2-M targeting, HeLa cells transfected 
with HLA-DR3, Ii and H2-M or H2-MA were analyzed by 
immunofluorescence staining with 16.23. Cells express- 
ing only DR3 and Ii displayed some 16.23 staining (as 
appears to be the case in HLA-DM-lacking B cell lines; 
see Fling et al., 1994; Mellins et al., 1990), occasionally 
located in vesicular structures, but this staining was con- 
sistently weak compared with the DR3 staining seen with 
the rabbit antiserum K503, recognizing the DRa tail (Fig- 
ures 8A, K503 and 88,16.23). When either H2-M or H2-MA 
was included in the transfection, the 16.23 staining was 
distinctly increased, with the majority of intracellular stain- 
ing located to vesicular structures. No difference in 18.23 
staining could be detected between cells transfected with 
H2-M (Figures 8C, K503 and 8D, 16.23) or H2-MA (Figures 
8E, K503 and 8F, 16.23). The vesicular staining of 16.23 
was largely coincident with lamp-l staining both in cells 
containing H2-M and in cells containing H2-MA (data not 
shown). The strong 16.23 staining of lamp-l-containing 
vesicular structures suggests that a large part of HLA-DR3 
either acquires peptide in a late endosomal or lysosomal 
compartment or travels through such a compartment after 
having acquired peptides. 
Discussion 
In comparison to the relatively well-characterized pathway 
leading to peptide loading of MHC class I molecules, little 
is known about antigen processing and presentation by 
MHC class II. The location where class II acquires peptides 
is debated and it remains unclear which components are 
required for class II-peptide association in antigen-pre 
senting cells. The class II-associated Ii is known to deliver 
class II to endosomal or lysosomal compartments (below 
these are generally referred to as endosomal) where pro- 
Figure 6. The Endosomal Targeting Motif in 
HP-M6 Is Not Essential for SDS-Stable Dimer 
Formation 
HeLa cells were transfected with HLA-DR3 and 
Ii (lip31133 and lip41) alone (lanes A) or to- 
gether with H2-M (lanes B) or H2-MA (lanes 
C). Cells were labeled 72 hr after transfection 
for 30 min with [“Slmethionine, washed, and 
either lysed (0) or incubated with nonradioac- 
tive medium for the times indicated (l-6 hr) 
before lysis. Radiolabeled DR molecules were 
immunoprecipitated with MAb DA6.147. Sam- 
ples were incubated in nonreducing SDS- 
PAGE sample buffer for 15 min at room temper- 
ature before loading on a 7.5%-12.5% SDS- 
PAGE gel. a indicates DRa monomers, 6 indi- 
cates DR6 monomers, Ii indicates lip31 and 33, 
ap indicates SDS-stable DR dimers. 
---- 
1 2 3 4 
nb b nb b nb b nb b 
lip31 + - + - 
lip31Al6 - + - + 
H-2M + + - - 
H-2MA - - + + 
Figure 7. Formation of SDS-Stable Class II Dimers Requires Tar- 
geting to Endosomal Compartments 
HeLa cells were transfected with HLA-DR3 (all lanes), H2-M, H2M(A), 
human lip31, and human lip31A16 in different combinations as indi- 
cated. Vector DNA was used to substitute for omitted DNAs as indi- 
cated. After transfection (72 hr). whole cell extracts in nonreducing 
SDS sample buffer were either boiled (b) or left at room temperature 
(nb) before being subjected to SDS-PAGE (10% polyacrylamide) and 
immunoblotting. Blots were probed with MAb DA6.147 (anti-DRa), fol- 
lowed by horseradish peroxidase-conjugated goat anti-mouse IgG. 
Lanes l-4 indicate different transfections; the first lane of each trans- 
fection was left at room temperature (nb), the second was boiled (b). 
Plus and minus indicate which DNAs (beside DR3)were included (plus) 
or not (minus) in the transfection. The 30 kDa band with equal intensity 
in all lanes is a background band, present also when the primary 
antibody is excluded. 
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Figure 6. HtA-DR3 with a Mature Conformation Is Present in EndosomallLysosomal Compartments both in the Presence and Absence of the 
H2-M Targeting Motif 
HeLa cells were transfected with HLA-DR3 and Ii only (A and B), with HLA-DR3, Ii, and H2-M (C and D), or with HLA-DR3, Ii, and H2-MA (E and 
F). Permeabilized cells were costained with rabbit antiserum K503 (anti-DRa tail) (A, C, E) and MAb 16.23 (6, D, F) followed by fluorescein-labeled 
goat anti-rabbit IgG and Texas red-labeled goat anti-mouse IgG. 
teolytic enzyme activity is required both for removal of 
the Ii and for generation of antigenic peptides (Blum and 
Cresswell, 1988; Neefjes and Ploegh, 1992). In addition 
the class II-like molecule, HLA-DM has been shown to be 
a necessary component for normal antigen processing in 
B-lymphoblastoid cell lines. The molecular action of 
HLA-DM appears to be facilitation of peptide exchange in 
other class II molecules (though this has been shown only 
for DR) (Sloan et al., 1995). The physiological substrate 
for this exchange mechanism is presently unclear, but is 
likely to be class II containing CLIP or class II containing 
poorly fitting peptides. The peptide exchange would then 
result in class II molecules containing well-fitting peptides. 
H2-M and HLA-DM have been shown to be located in 
endosomal compartments and this prompted us to investi- 
gate the signals responsible for this localization and their 
importance for H2-M function. Here, we report that the 
cytoplasmic tail of HPM8 contains a strong targeting sig- 
nal that is sufficient to localize H2-M (or a reporter mole- 
cule) to endosomal compartments. Somewhat surpris- 
ingly, we find the targeting motif not to be essential either 
for peptide loading of class II or for endosomal location 
of H2-M in cells expressing normally targeted versions 
of Ii. 
Two types of targeting motifs have been described for 
transmembrane proteins located to endosomal and lyso- 
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somal compartments (reviewed by Sandoval and Bakke, 
1994). These motifs, though highly variable in sequence, 
are either tyrosine or leucine based. It is not possible to 
deduct the final location of a protein based on the se- 
quence of the targeting motif (Luzio and Banting, 1993). 
Similar-looking motifs direct the transferrin receptor (YTRF) 
to early endosomes, Lamp-l (YQTI) to lysosomes and 
TGN-38 (YQRL) to the trans-Golgi network. Some proteins 
have been shown to contain several motifs, either tyrosine 
or leucine based (Johnson and Kornfeld, 1992; Letourneur 
and Klausner, 1992). Ii, for example, contains two leucine- 
based motifs, which are responsible for its endosomal tar- 
geting (Bremnes et al., 1994; Odorizzi et al., 1994). 
H2-M expressed in HeLa cells, in the absence of Ii, is 
almost entirely located to a late endosomal or lysosomal 
compartment. One of the two tyrosines present in the cyto- 
plasmic tail of HP-MO, Y230, is surrounded by amino acids 
suggestive of a targeting motif, YTPL (Cho et al., 1991; 
Karlsson et al., 1994). The same motif is present in HLA- 
DM6 and has been proposed to be responsible for the 
localization of HLA-DM to MIIC, a morphologically defined 
class II-containing structure (Sanderson et al., 1994). 
We found that the targeting information in H2-M was 
confined to the HP-M8 cytoplasmic tail (Figure 2) and, 
more specifically, that it was indeed mediated by the motif 
containing Y230, with little or no influence from the other 
tyrosine residue, Y238. The fact that the targeting signal 
is fully functional when transferred to a reporter molecule 
(H2-Ak, Figure 3) suggests that other partsof H2-M, includ- 
ing the short H2-Ma tail, do not substantially influence the 
targeting. 
Our finding that targeting-deficient H2-M molecules are 
redirected to endosomal compartments by cotransfection 
of Ii (Figure 4) suggested that targeting of Ii could substi- 
tute for the missing H2-M targeting motif. We have pre- 
viously shown that H2-M and Ii can be coimmunoprecipi- 
tated from mouse splenocyte lysates (Karlsson et al., 
1994) but Denzin et al. (1994) have reported that human 
HLA-DM does not bind to Ii and it was therefore important 
to show whether the two molecules do indeed associate. 
We found that if transfected cells were lysed in Triton 
X-100, little Ii could be coprecipitated with H2-M. If the 
cells were lysed in digitonin, however, the association of 
the Ii and H2-M was apparent (Figure 5). Denzin et al. did 
not use digitonin in their experiments. Therefore, it is likely 
that weak or transient association between the Ii and 
HLA-DM can account for their result, though species differ- 
ences or antibody interference may be responsible. 
We have previously reported the introduction of efficient 
peptide loading of class II in HeLa cells transiently trans- 
fected with only class II, Ii, and H2-M. In this study, we 
used this system to investigate the functional significance 
of the HPMf3 targeting motif (Figures 6 and 7). Somewhat 
unexpectedly, we were not able to detect any differences 
in peptide loading onto class II (measured by SDS-stable 
dimer formation in SDS-PAGE) between the wild-type and 
targeting-deficient constructs. Two main explanations for 
the existence of the targeting motif seemed possible; ei- 
ther H2-M may be able to exercise its function at any loca- 
tion in the cell and only by strictly targeting it to a special 
organelle can undesired loading events (for example of 
self-peptides) be avoided. This would be especially im- 
portant if class II associated with Ii is a substrate for H2-M. 
Alternatively, H2-M is only active in the endosomal system, 
potentia!ly only in the MIIC, and it is targeted there for that 
reason. We have no data supporting the hypothesis that 
H2-M could be active outside of the endosomal system 
and the recent data from Sloan et al. (1995) show HLA-DM 
to be most active at acidic pH, between 4.5-5.5. At pH 
7.0, HLA-DM appears to be inactive and it is therefore 
unlikely that it (or H2-M) could be active at the cell surface 
or in the endoplasmic reticulum where the pH is thought 
to be neutral (Wilson et al., 1993). The Golgi apparatus 
appears to be mildly acidic with a reported pH of >6 in the 
rrans-Golgi (Seksek et al., 1995) and thus some HLA-DM 
activity can not be excluded in this location. 
Several lines of evidence, in contrast, suggest that H2-M 
is active only in the endosomal system also in the absence 
of its targeting motif. Thus, in the presence of Ii, we found 
H2-M to be present in lamp-l -positive compartments, inde- 
pendently of whether it contained the targeting motif or 
not (though the nontargeted molecule was also present 
at the cell surface) and the efficiency with which class II 
became SDS-stable was equivalent in both cases (Figures 
6 and 7). If the endosomal targeting signal was removed 
from the Ii, however, SDS-stable DR3dimers wereabsent, 
confirming that endosomal delivery of class II is essential 
for the formation of stable dimers (Figure 7). This is not 
surprising, considering that endosomal degredation of in- 
variant chain appears to be a prerequisite for peptide 
loading. 
The conclusion that class II, expressed together with 
wild-type Ii and H2-M, acquires peptide in endosomes also 
in the absence of an H2-M targeting motif was reinforced 
by the pattern of intracellular staining with the MAb 16.23, 
shown to be preferentially reactive with mature possibly 
peptide-loaded forms of HLA-DRS. Immunofluorescence- 
staining with 16.23 showed identical endosomal staining 
patterns in cells expressing HLA-DR3 and Ii together with 
either wild-type or a targeting-deficient form of H2-M. 
The data presented here demonstrate the existence of 
an endosomal targeting motif in the HPM8 tail, but they 
also show that this motif is not necessary for the formation 
of mature SDS-stable class II dimers. Our conclusion is 
that the H2-M targeting motif is present to improve the 
efficiency of H2-M sorting, but that itseffect on H2-M func- 
tion is subtle and can be substituted by the targeting infor- 
mation present in the Ii. 
Experimental Procedures 
Cell Culture and Transient Transfections 
HeLa cells were grown in Dulbecco’s modified Eagle’s medium (DMEM; 
GIBCO)supplemented with 7% fetal calf serum, 2 mM glutamine, 100 
U streptomycin, and 100 U penicillin at 37’C in an atmosphere of 
5% CO*, 35% air, and passaged every other day. Transfections were 
carried out as described (Nilsson et al.. 1989) except that 25 pg of 
DNA and 5 x lo5 cells was used per transfection. Each transfection 
was performed in a 100 mm Petri dish. 
The following amounts of DNA were used for transfections. For 
Figure 2, 4 pg of a plasmid containing human CD6a in pCMU was 
used together with 4 ng of each H2-M cDNA plasmid (a and 6 chain 
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constructs as indicated in the figure legend), and 13 ug of vector. For 
Figure 3,4 pg of each H2-AL cDNA plasmid (a and 8 chain constructs 
as indicated in the figure legend), and 17 ng of vector. For Figure 4, 
4 ng of each H2-M cDNA plasmid (a and BA), 7 ug of murine 87-2 
plasmid, and either IO ng of vector (A and B) or 10 ug of human lip31 
(C-H). For Figure 5, 3.75 ng of each H2-M plasmid (a and pa), and 
17.5 ng of human lip31A16 plasmid. For Figure 6, 3.5 ng of each DR 
plasmid (HLA-DRA and HLA-DRB3), 10 ug of human Ii plasmids (lip31 I 
33 and lip41), and 2 ug each of H2-M cDNA plasmids (a and 8) (lanes 
B and C) or 4 pg of vector (lanes A). For Figure 7, 5 ng of each DR 
plasmid (HLA-DRA and HLA-DRB3), 10 ug of human Ii plasmids (lip31 
or lip31 A16), and 2.5 ug each of H2-Ma and either HP-M8 or HP-M6A. 
For Figure 6, HLA-DRA, HLA-DRBS. H2-Ma, HP-M6 (or H2-MDA), hu- 
man lip31, and human lip41 were transfected in molar ratios 9:9:1: 
1:150:30. Vector DNA was used to substitute for omitted DNAs as 
indicated. 
Antlbodles 
The hybridoma lines 10-2-16 (Oi et al., 1976) DA6.147 (Guy et al., 
1962) 16.23 (Johnson et al., 1962) OKT6 (Hoffman et al., 1960) have 
been described elsewhere, as has the rabbit antisera K553 (Karlsson 
et al., 1994) and K455 (Rask et al., 1976). Rabbit antiserum K503 was 
raised against a KLH-coupled peptide derived from the cytoplasmic tail 
of HLA-DRA (KGVRKSNAAERRGPL). Antibodies (mouse and rabbit) 
reactive with human lamp-l were gifts from M. Fukuda (La Jolla Cancer 
Research Foundation). VicYl was a gift from W. Knapp (Institut fur 
lmmunologie der Universitat Wien). GLl was purchased from Phar- 
mingen (San Diego, California), 8045 was purchased from The Binding 
Site (San Diego, California) 
Recombinant DNA 
H2-ABk was modified by polymerase chain reaction (PCR) to introduce 
an Xbal site immediately after the transmembrane domain using the 
5’ primer 5’AAAAGCTTCCACCATGGCTCTGCAGATCCCC3’ and 
the 3’ primer 5”TTTTCTAGAACGGATGAAAAGGCCAAGC-3’. The in- 
troduced Xbal site changed amino acid His-222 to Ser. The PCR was 
done according to a standard protocol and the PCR fragment was 
purified by Geneclean according to recommendations from the manu- 
facturer(Biol01). Thepurifiedfragmentwasclonedintotheexpression 
vector pCMU (Nilsson et al., 1989) between Ncol and Xbal. The re- 
sulting plasmid was used for further directional cloning of oligonucleo- 
tides between the unique Xbal and Kpnl sites in this plasmid. The 
sequences for the oligonucleotides used to construct H2-Ah/M, HZ-AY 
M(230Y - A) and H2-AYM(238Y - A) were derived from the last 20 
aa(carboxy terminal) of the H2-Mj32 sequence (Karlsson et al., 1994). 
Tyrosine to alanine replacement mutations in these constructs were 
made by changing the tyrosine codon TAC to the alanine codon GCC. 
The oligonucleotides contained an open Xbal site in the 5’ end and 
a stop codon followed by an open Kpnl site in the 3’ end. 
HP-M8 chimeric constructs were made by transfer of a cloned H2- 
Mj32 fragment into the H2-ABk constructs described above. The H2- 
Mf32 fragment was generated by PCR using a H2-Mj32k full-length 
cDNA as template. Primers used were the following: 5’ primer 5’- 
AAGAATTCCACCATGGCTGCACTCTGGCTGCT-3’ and 3’ primer 5’- 
TlTGTCGAC-TAGTTCTGAAGAAGCCAACACAGAA3’. The fragment 
was originally cloned blunt into the EcoRV site of pBluescript KS(+). 
Ncol and Spel were used to excise the fragment for transfer into the 
H2-AL constructs opened with Ncol and Xbal. 
Human lip31 and lip41 contains the full-length (216 and 280 aa, 
respectively) Ii sequences cloned into pCMU. Human lip31133 gives 
rise to two transcripts, encoding lip31 and lip33. This plasmid gives 
lower expression than the lip31 and lip41 clones. Human lip31A16 in 
pCMU has been described elsewhere (Lotteau et al., 1990). It is a 
truncation mutant that lacks the first 15 aa, containing the two endoso- 
mal targeting motifs. 
All constructs were sequenced directly in the expression plasmid 
using pCMU-specific primers. 
lmmunofluorescence Microscopy and 
Cytofluorometry Analysls 
HeLa cells were split 48 hr after transfection and seeded onto glass 
cover slips. Cells were fixed 72 hr after transfection in 4% formalde- 
hyde in phosphate-buffered saline (PBS) for 30 min. Cells were perme- 
abilized with 0.2% saponin in PBS containing 0.8% Fish skin gelatin 
(PBS, FSG, saponin). Primary antibody incubations were made in this 
solution. Cells were washed repeatedly in PBS, FSG, saponin before 
the secondaryfluorescein- or Texas red-labeled secondary antibodies 
(Molecular Probes) were added. Cells were washed with PBS and 
mounted in mowiol (Calbiochem). Fluorescence microscopy was per- 
formed using a Zeiss axiophot microscope with a 63 x objective. 
For cytofluorometry (FACS) analysis, transfected cells were treated 
with 2 mM EDTA in PBS to detach the cells from the Petri dishes. Cell 
suspensions (2 x lO”cells/sample) were washed with PBS containing 
0.5% fetal calf serum (FCS) and 0.05% sodium aside at +4OC. Incuba- 
tion with primary antibody was carried out for 1 hr at +4OC in 0.5% 
FCSlPBS with 0.05% sodium azide. The cells were washed three 
times and incubated with secondary antibody for 1 hr. Finally, the cells 
were washed three times with FCS, PBS, azide and two times with 
PBS before being subjected to cytofluorometryanalysis using a Becton 
Dickinson FACS440. 
Cell Labelings and lmmunopreclpltatlons 
Cells were incubated 72 hr after transfection in methionine-free (Figure 
6) or methionine- and cysteine-free (Figure 5) DMEM for 15 min prior 
to addition of labeling medium. Cells were labeled at 37OC for the 
times indicated with 0.2 mCi [%S]methionine per 100 mm dish (Figure 
6) or 0.2 mCi [“Slmethionine and 0.2 mCi [“Sjcysteine (Figure 5). 
Cells were then either lysed or chased in normal culture medium for 
the times indicated. For Figure 6, cells were lysed in 1% Triton X-100 
with 2 mM PMSF in PBS for 15 min. Lysates were spun at 15,000 x 
g for IO min before preclearing with protein A-Sepharose (Pharmacia). 
After removal of the protein A-Sepharose beads, lysates were incu- 
bated with the primary antibody (DA8.147) for 2 hr. Antibody precipi- 
tates were harvested with protein A-Sepharose and after washing four 
times with 0.1% Triton X-100 in PBS, samples were incubated in SDS 
sample buffer containing 2% SDS for 15 min at room temperature 
before loading on 7.5%-l 2.5% SDS-PAGE slab gels. Gels were fixed 
in 10% acetic acid and 20% methanol before drying and autoradiog- 
raphy. 
For Figure 5, cells were lysed 1% digitonin, 25 mM HEPES (pH 
7.8) 10 mM KCI, 10 mM CaC&, 5 mM MgC&, 2 mM PMSF, 10 mM 
leupeptin, and 5 mM iodoacetamide. Lysates were treated as for Figure 
6, except that antibodies used were K553 and B645, that B645 was 
harvested with protein G-Sepharose, that samples were washed in 
0.1% digitonin, and that the samples were subjected to two-dimensional 
gel electrophoresis as described previously (Karlsson and Peterson, 
1992). Ampholines (Pharmacia) pH 3-10 were used. Slab gels were 
7.5%-12.5%. 
lmmunoblotting 
Transfected cells were detached from the Petri dishes with 2 mM EDTA 
in PBS 72 hr after transfection. The cells were lysed in 1% NP-QO in 
PBS. Nuclei were spun down and the supernatant was diluted with 
an equal amount of SDS-sample buffer containing 4% SDS. Samples 
were split into two portions. One portion was boiled for 5 min and the 
other portion was left at room temperature. Samples were separated 
on 10% polyacrylamide gels and blotted onto lmmobilon P membranes 
(Millipore). Blots were prehybridized with 3% defatted skim milk in PBS 
and hybridized with the mouse MAb DA6.147. The bound antibody was 
detected using horseradish peroxidase-labeled antibody to mouse 
immunoglobulin(Bio-Rad)together withenhancedchemiluminiscence 
(ECL, Amersham). 
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